WELL HEALTH TECHS WKN: A2JQV6 ISIN: CA94947L1022 Kürzel: WELL Forum: Aktien Thema: Hauptdiskussion

https://www.prnewswire.com/news-releases/well-health-reports-record-results-for-q2-2024-driven-by-an-acceleration-in-organic-growth-and-raises-annual-guidance-302222234.html

https://finance.yahoo.com/news/well-health-reports-record-quarterly-110000580.html

WELL Provides Integration Update with Focus on Streamlining Business Operations for Improved Profitable Growth https://www.newswire.ca/news-releases/well-provides-integration-update-with-focus-on-streamlining-business-operations-for-improved-profitable-growth-845669667.html

https://betakit.com/fuelled-by-well-health-partnership-healwell-looks-to-apply-ai-to-preventative-care/

RBC Capital starts coverage on Well Health Technologies with Outperform rating https://www.google.com/amp/s/m.uk.investing.com/news/stock-market-news/rbc-capital-starts-coverage-on-well-health-technologies-with-outperform-rating-93CH-3325398%3fampMode=1

WELL Health Announces Record Patient Visits and Total Care Interactions for Q4-2023 and Projects Record Revenue and Positive EPS for the Quarter https://www.newswire.ca/news-releases/well-health-announces-record-patient-visits-and-total-care-interactions-for-q4-2023-and-projects-record-revenue-and-positive-eps-for-the-quarter-851115001.html

"WELL faced margin headwinds across its business in 2023 and we expect margins to remain pressured into 2024, slowing EBITDA growth,” he said. “We are also adjusting our valuation to better account for shareholders’ portion of WELL’s EBITDA, leading to a reduction in our price target from $5.50 to $4.75. We prefer a wait-and-see approach as WELL works to implement cost savings initiatives and integrates recent acquisitions. In addition to the WELL downgrade and price target change, we are rolling our financial models forward to 2025 for all three companies and updating our price target calculations.”

Emera, Mullen Group, Well Health Technologies https://www.tradingview.com/news/reuters.com,2024:newsml_L4N3EC17I:0-emera-mullen-group-well-health-technologies/ Securities analysts revised their ratings and price targets on several Canadian companies, including Emera, Mullen Group and Well Health Technologies, on Monday. ... *CIBC cuts to from outperformer *CIBC cuts target price to C$4.75 from C$5.50

https://news-releases.well.company/news-releases/well-health-provides-business-update-demonstrating-focus-on-profitable-and-capital-efficient-growth/

https://www.prnewswire.com/news-releases/well-health-announces-launch-of-well-ai-inbox-admin-a-revolutionary-ai-powered-solution-for-clinic-inbox-management-301994377.html

https://www.prnewswire.com/news-releases/well-health-reports-record-results-for-q3-2023-raises-guidance-for-balance-of-2023-and-provides-guidance-of-over-900-million-in-revenue-for-2024-301987260.html

https://www.prnewswire.com/news-releases/well-health-launches-well-longevity-a-program-designed-to-provide-the-most-advanced-preventative-care-available-301982920.html

https://finance.yahoo.com/news/well-health-announces-record-patient-120000122.html

WELL Health Launches 'WELL AI Decision Support' powered by HEALWELL AI; Empowering Healthcare Providers with Next Generation Decision Support Systems https://www.newswire.ca/news-releases/well-health-launches-well-ai-decision-support-powered-by-healwell-ai-empowering-healthcare-providers-with-next-generation-decision-support-systems-823365904.html

WELL Health Completes Clinic Acquisition and Investment Transactions with HEALWELL AI Inc. (formerly MCI Onehealth), and Forms Strategic Alliance Focused on Developing AI Enabled Disease Detection and Preventative Care Tools for Care Providers https://www.prnewswire.com/news-releases/well-health-completes-clinic-acquisition-and-investment-transactions-with-healwell-ai-inc-formerly-mci-onehealth-and-forms-strategic-alliance-focused-on-developing-ai-enabled-disease-detection-and-preventative-care-tools-for-c-301945558.html

WELL Health Technologies GAAP EPS of C$0.06, revenue of C$170.9M https://seekingalpha.com/news/4001127-well-health-technologies-gaap-eps-of-c006-revenue-of-c1709m • WELL Health Technologies press release (OTC:WHTCF): Q2 GAAP EPS of C$0.06. • Revenue of C$170.9M (+21.8% Y/Y). • WELL Health upgraded guidance, expecting 2023 revenue to be in the upper half of annual guidance of $740M to $760M.  • Annual adjusted EBITDA is expected to increase by more than 10% over 2022 levels.  • WELL also announced that its OceanMD subsidiary signed a multi-year C$38.5M contract.